Moleculin Biotech (MBRX) Reports Q1 Result

Go back to Moleculin Biotech (MBRX) Reports Q1 Result
METABASIS THERAPEUT (NASDAQ: MBRX) Delayed: 2.28 -0.16 (6.56%)
Previous Close $2.44    52 Week High $9.58 
Open $2.43    52 Week Low $2.34 
Day High $2.43    P/E N/A 
Day Low $2.25    EPS $-0.34 
Volume 139,220